Skip to main content

NAPROXEN

NDC 49483-617 · TIME CAP LABORATORIES

Generic nameNAPROXEN
Dosage formTABLET
RouteORAL
Active ingredient(s)NAPROXEN
Strength375 mg/1
Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
Marketing categoryANDA

Packages

49483-617-01 — 100 TABLET in 1 BOTTLE, PLASTIC (49483-617-01)

49483-617-50 — 500 TABLET in 1 BOTTLE, PLASTIC (49483-617-50)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42494-454 — Naproxen, 42708-043 — Naproxen, 42708-140 — NAPROXEN, 43063-600 — Naproxen, 43063-650 — Naproxen, 43063-920 — NAPROXEN, 43353-211 — Naproxen, 43353-216 — Naproxen, 43353-218 — Naproxen, 45865-238 — Naproxen, 49483-618 — NAPROXEN, 49483-619 — NAPROXEN, 50090-0481 — Naproxen, 50090-0482 — Naproxen, 50090-0483 — Naproxen, 50090-1583 — Naproxen, 50090-1584 — Naproxen, 50090-1585 — Naproxen, 50090-2788 — Naproxen, 50090-4636 — Naproxen, +171 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels